Tuesday, October 23, 2018 12:29:13 PM
Breaking a string of 57 straight losing quarters will take sales, and Keith's focus ought to be entirely on having deals ready and in place if/when full FDA clearance is provided. Operations will need to be ready and able to supply product, among a myriad of other critical items. Placing that on top of Keith's current duties is not a good idea - and it wouldn't do a thing to help the PPS, IMO. The PPS would benefit more by teaching Andy how to properly pronounce 'opioid' than it would by slamming Keith with COO duties.
The amount of work is just for starters - doesn't even begin to address the issue as to whether Keith is cut out for a COO role (not many marketing/sales personnel are - yes, a generalization, but a fair one).
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM